Alpha DNA Investment Management’s Everpure Inc P Stock Holding History

Alpha DNA Investment Management’s Portfolio P Stock Details P Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,256	Closed	-$527K	–	194
2022 Q3	$527K	Sell	19,256 -17,654	-48%	-$499K	0.44%	121
2022 Q2	$947K	Buy	+36,910	New	+$1.02M	0.81%	78
2022 Q1	–	Sell	-47,326	Closed	-$1.54M	–	144
2021 Q4	$1.54M	Sell	47,326 -8,439	-15%	-$245K	0.97%	60
2021 Q3	$1.4M	Sell	55,765 -13,613	-20%	-$301K	0.95%	59
2021 Q2	$1.35M	Buy	69,378 +69,237	+49,104%	+$1.36M	0.92%	78
2021 Q1	$3K	Buy	+141	New	+$3.35K	﹤0.01%	504

Other funds holding P

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Alpha DNA Investment Management's P Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Everpure Inc (P) in Q4 2022, closing a stake of 19,256 shares — an estimated $527K sold.

Alpha DNA Investment Management first reported a position in P in Q1 2021 and held it in 6 quarters. The position peaked at $1.54M in Q4 2021. 436 funds tracked by Wall St. Rank hold P as of Q4 2022.

Alpha DNA Investment Management reported no remaining Everpure Inc position as of Q4 2022 after selling out during the quarter.
Alpha DNA Investment Management sold 19,256 Everpure Inc shares in Q4 2022, an estimated $527K.
Alpha DNA Investment Management first reported a position in Everpure Inc in Q1 2021 and held it in 6 quarters.
Alpha DNA Investment Management's Everpure Inc position peaked at $1.54M in Q4 2021.
436 funds tracked by Wall St. Rank held Everpure Inc as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.